{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:56:28Z","timestamp":1768877788845,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000948","name":"Pfizer Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000948","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.03.084","type":"journal-article","created":{"date-parts":[[2012,4,14]],"date-time":"2012-04-14T02:20:12Z","timestamp":1334370012000},"page":"3983-3985","source":"Crossref","is-referenced-by-count":24,"title":["Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease"],"prefix":"10.1016","volume":"30","author":[{"given":"B.","family":"Suthers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Thambar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Peel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.03.084_bib0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","article-title":"Phosphorylcholine-targeting immunization reduces atherosclerosis","volume":"50","author":"Caligiuri","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.07.009","article-title":"Low levels of IgM antibodies against phosphorylcholine\u2014a potential marker for ischaemic stroke in men","volume":"203","author":"Sjoberg","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0025","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","article-title":"Immunoglobulin M type of autoantibodies to oxidised low density lipoprotein has an inverse relation to carotid artery atherosclerosis","volume":"108","author":"Karvonen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/HAB-2009-0202","article-title":"Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease","volume":"18","author":"Soto","year":"2009","journal-title":"Human Antibodies"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0070","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","article-title":"Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?","volume":"110","author":"Shoenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","article-title":"Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease","volume":"134","author":"Frostegard","year":"2010","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0961203311398884","article-title":"Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome","volume":"20","author":"Laczik","year":"2011","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.vaccine.2012.03.084_bib0080","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidised LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2007.04.054","article-title":"Promise of immune modulation to inhibit atherogenesis","volume":"50","author":"Binder","year":"2007","journal-title":"JACC"},{"issue":"8","key":"10.1016\/j.vaccine.2012.03.084_bib0085","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1503\/cmaj.070221","volume":"179","author":"Lamontagne","year":"2008","journal-title":"CMAJ"},{"issue":"17","key":"10.1016\/j.vaccine.2012.03.084_bib0090","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/jama.2010.529","article-title":"Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men","volume":"303","author":"Tseng","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0095","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/ije\/dyp343","article-title":"Cohort profile: the Hunter community Study","volume":"39","author":"McEvoy","year":"2010","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.vaccine.2012.03.084_bib0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1532-5415.1997.tb01001.x","article-title":"Autoantibodies against oxidized low density lipoproteins in older stroke patients","volume":"45","author":"Cherubini","year":"1997","journal-title":"Journal of the American Geriatrics Society"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T08:57:12Z","timestamp":1561625832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12004926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":15,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12004926"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}